193 related articles for article (PubMed ID: 23398788)
1. Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study.
Choi JH; Rhee EJ; Bae JC; Park SE; Park CY; Cho YK; Oh KW; Park SW; Lee WY
Arch Med Res; 2013 Feb; 44(2):115-20. PubMed ID: 23398788
[TBL] [Abstract][Full Text] [Related]
2. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes.
Fracanzani AL; Valenti L; Bugianesi E; Andreoletti M; Colli A; Vanni E; Bertelli C; Fatta E; Bignamini D; Marchesini G; Fargion S
Hepatology; 2008 Sep; 48(3):792-8. PubMed ID: 18752331
[TBL] [Abstract][Full Text] [Related]
3. The severity of nonalcoholic fatty liver disease is associated with increased cardiovascular risk in a large cohort of non-obese Asian subjects.
Sung KC; Ryan MC; Wilson AM
Atherosclerosis; 2009 Apr; 203(2):581-6. PubMed ID: 18774133
[TBL] [Abstract][Full Text] [Related]
4. Insulin resistance is independently associated with liver aminotransferases in diabetic patients without ultrasound signs of nonalcoholic fatty liver disease.
Esteghamati A; Noshad S; Khalilzadeh O; Khalili M; Zandieh A; Nakhjavani M
Metab Syndr Relat Disord; 2011 Apr; 9(2):111-7. PubMed ID: 21091060
[TBL] [Abstract][Full Text] [Related]
5. The Effects of Extra Virgin Olive Oil on Alanine Aminotransferase, Aspartate Aminotransferase, and Ultrasonographic Indices of Hepatic Steatosis in Nonalcoholic Fatty Liver Disease Patients Undergoing Low Calorie Diet.
Shidfar F; Bahrololumi SS; Doaei S; Mohammadzadeh A; Gholamalizadeh M; Mohammadimanesh A
Can J Gastroenterol Hepatol; 2018; 2018():1053710. PubMed ID: 29850450
[TBL] [Abstract][Full Text] [Related]
6. Serum retinol-binding protein 4 in patients with nonalcoholic fatty liver disease: does it have a significant impact on pathogenesis?
Cengiz C; Ardicoglu Y; Bulut S; Boyacioglu S
Eur J Gastroenterol Hepatol; 2010 Jul; 22(7):813-9. PubMed ID: 19820404
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and associated factors of non-alcoholic fatty liver disease in patients with type-2 diabetes mellitus.
Leite NC; Salles GF; Araujo AL; Villela-Nogueira CA; Cardoso CR
Liver Int; 2009 Jan; 29(1):113-9. PubMed ID: 18384521
[TBL] [Abstract][Full Text] [Related]
8. The risk factors for ultrasound-diagnosed non-alcoholic fatty liver disease among adolescents.
Fu CC; Chen MC; Li YM; Liu TT; Wang LY
Ann Acad Med Singap; 2009 Jan; 38(1):15-7. PubMed ID: 19221666
[TBL] [Abstract][Full Text] [Related]
9. Elevation of serum aminotransferase activity increases risk of carotid atherosclerosis in patients with non-alcoholic fatty liver disease.
Wang CC; Lin SK; Tseng YF; Hsu CS; Tseng TC; Lin HH; Wang LY; Kao JH
J Gastroenterol Hepatol; 2009 Aug; 24(8):1411-6. PubMed ID: 19702910
[TBL] [Abstract][Full Text] [Related]
10. Nonalcoholic fatty liver disease is associated with an almost twofold increased risk of incident type 2 diabetes and metabolic syndrome. Evidence from a systematic review and meta-analysis.
Ballestri S; Zona S; Targher G; Romagnoli D; Baldelli E; Nascimbeni F; Roverato A; Guaraldi G; Lonardo A
J Gastroenterol Hepatol; 2016 May; 31(5):936-44. PubMed ID: 26667191
[TBL] [Abstract][Full Text] [Related]
11. Association between serum vitamin B12 levels and the degree of steatosis in patients with nonalcoholic fatty liver disease.
Koplay M; Gulcan E; Ozkan F
J Investig Med; 2011 Oct; 59(7):1137-40. PubMed ID: 21804402
[TBL] [Abstract][Full Text] [Related]
12. Nonalcoholic Fatty Liver Disease and Risk of Diabetes: A Prospective Study in China.
Shen X; Cai J; Gao J; Vaidya A; Liu X; Li W; Chen S; Zhou Y; Li Y; Zhang Y; Zhao J; Hu FB; Wu S; Gao X
Endocr Pract; 2018 Sep; 24(9):823-832. PubMed ID: 29975579
[TBL] [Abstract][Full Text] [Related]
13. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
[TBL] [Abstract][Full Text] [Related]
14. The Relationship Between Liver Enzymes and Insulin Resistance in Type 2 Diabetes Patients with Nonalcoholic Fatty Liver Disease.
Sheng X; Che H; Ji Q; Yang F; Lv J; Wang Y; Xian H; Wang L
Horm Metab Res; 2018 May; 50(5):397-402. PubMed ID: 29723898
[TBL] [Abstract][Full Text] [Related]
15. Factors related to non-alcoholic fatty liver disease in obese children.
Eminoğlu TF; Camurdan OM; Oktar SO; Bideci A; Dalgiç B
Turk J Gastroenterol; 2008 Jun; 19(2):85-91. PubMed ID: 19110662
[TBL] [Abstract][Full Text] [Related]
16. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study.
Adams LA; Waters OR; Knuiman MW; Elliott RR; Olynyk JK
Am J Gastroenterol; 2009 Apr; 104(4):861-7. PubMed ID: 19293782
[TBL] [Abstract][Full Text] [Related]
17. Modifiable clinical and lifestyle factors are associated with elevated alanine aminotransferase levels in newly diagnosed type 2 diabetes patients: results from the nationwide DD2 study.
Mor A; Svensson E; Rungby J; Ulrichsen SP; Berencsi K; Nielsen JS; Stidsen JV; Friborg S; Brandslund I; Christiansen JS; Beck-Nielsen H; Sørensen HT; Thomsen RW
Diabetes Metab Res Rev; 2014 Nov; 30(8):707-15. PubMed ID: 24639417
[TBL] [Abstract][Full Text] [Related]
18. Risk of Cirrhosis and Hepatocellular Cancer in Patients With NAFLD and Normal Liver Enzymes.
Natarajan Y; Kramer JR; Yu X; Li L; Thrift AP; El-Serag HB; Kanwal F
Hepatology; 2020 Oct; 72(4):1242-1252. PubMed ID: 32022277
[TBL] [Abstract][Full Text] [Related]
19. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values.
Mofrad P; Contos MJ; Haque M; Sargeant C; Fisher RA; Luketic VA; Sterling RK; Shiffman ML; Stravitz RT; Sanyal AJ
Hepatology; 2003 Jun; 37(6):1286-92. PubMed ID: 12774006
[TBL] [Abstract][Full Text] [Related]
20. The persistence of fatty liver has a differential impact on the development of diabetes: The Kangbuk Samsung Health Study.
Bae JC; Han JM; Cho JH; Kwon H; Park SE; Park CY; Lee WY; Oh KW; Kwon S; Park SW; Rhee EJ
Diabetes Res Clin Pract; 2018 Jan; 135():1-6. PubMed ID: 29111276
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
